ArticleCancers2024

Adverse Reactions in Relapsed/Refractory B-Cell Lymphoma Administered with Chimeric Antigen Receptor T Cell Alone or in Combination with Autologous Stem Cell Transplantation.

Haolong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.